Telemonitoring of Geriatric Cancer Patients Using Handheld Devices

Telemonitoring of Geriatric Cancer Patients Using Handheld Devices (TeleGraPH)

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03196050

Enrollment

Registered

2017-06-22

Start date

2016-11-30

Completion date

2018-12-31

Last updated

2019-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

Cancer is becoming a chronic disease, with the requirement of a lifelong intake of cancer-controlling drugs. While young(er) patients may cope with this, geriatric cancer patients may require a more customized and tailored follow up. Most elderly patients have multiple other diseases (comorbidities) and, due to many other factors, may per se not tolerate or simply not follow anticancer therapies. This may not only impair quality of life (QoL), but on the long rung also the therapeutic outcome (survival). Handheld devices provide a new reporting/communication tool for patients and health care providers. TeleGraPH will assess if these devices are a suitable communication modality in a cohort of geriatric cancer patients.

Interventions

DEVICEHandheld Device (Smart Phone)

Handheld device will be used for 3 tasks: 1x per day: status update (how are you today?) 1x per week: 10 questions on general health status 1x per month: EORTC QLQ-C30 questionnaire

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

60 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age \> 60 years * Karnofsky Performance Status ≥ 70 * histologically confirmed malignant tumor (cancer)

Exclusion criteria

* concurrent severe and/or uncontrolled concomitant medical conditions * Patients unwilling or unable to comply with using a handheld device

Design outcomes

Primary

Measure	Time frame	Description
Device Adherence/Compliance	1 Year	Frequency of using the handheld device and of daily/weekly/monthly reportings

Secondary

Measure	Time frame	Description
Quality of Life	1 Year	Assessed using the EORTC QLQ-C30 questionnaire
Reliability of reports	1 Year	Patient-reported status will be compared to physician-rated status

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026